ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Order Full text via Infotrieve
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matusiewicz, S.
Right arrow Articles by Greening, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matusiewicz, S.
Right arrow Articles by Greening, A.
Eur Respir J 1993; 6: 1282-1286
Copyright © ERS Journals Ltd 1993


Original Articles

Plasma lactate dehydrogenase: a marker of disease activity in cryptogenic fibrosing alveolitis and extrinsic allergic alveolitis?

SP Matusiewicz, IJ Williamson, PJ Sime, PH Brown, PR Wenham, GK Crompton, and AP Greening

Total plasma lactate dehydrogenase (LDH) activity may be elevated in cryptogenic fibrosing alveolitis (CFA) and extrinsic allergic alveolitis (EAA), and may be a useful monitor of disease progress. In a retrospective, primary referral centre study, we compared LDH at presentation, prior to bronchoalveolar lavage BAL, and after treatment and follow-up with changes in pulmonary function, in patients with CFA, EAA and pulmonary sarcoidosis. Plasma levels of LDH at presentation in CFA (n = 47) and EAA (n = 10) were significantly higher than in patients with sarcoidosis (n = 36). LDH activity decreased in patients with improving lung function (EAA, p = 0.008; CFA, p = 0.02), whereas it increased in CFA patients with deteriorating lung function (p = 0.015). Total plasma LDH is a simple, though nonspecific test, which appears to reflect changes of disease activity in patients with CFA and EAA.


This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
A. Turna, O. Solak, E. Cetinkaya, A. Kilicgun, M. Metin, A. Sayar, and A. Gurses
Lactate dehydrodgenase levels predict pulmonary morbidity after lung resection for non-small cell lung cancer
Eur. J. Cardiothorac. Surg., September 1, 2004; 26(3): 483 - 487.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
D. Karan, D. L. Kelly, A. Rizzino, M.-F. Lin, and S. K. Batra
Expression profile of differentially-regulated genes during progression of androgen-independent growth in human prostate cancer cells
Carcinogenesis, June 1, 2002; 23(6): 967 - 976.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
K Tsukamoto, H Hayakawa, A Sato, K Chida, H Nakamura, and K Miura
Involvement of Epstein-Barr virus latent membrane protein 1 in disease progression in patients with idiopathic pulmonary fibrosis
Thorax, November 1, 2000; 55(11): 958 - 961.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
H. TAKAHASHI, Y. KUROKI, H. TANAKA, T. SAITO, K. KUROKAWA, H. CHIBA, A. SAGAWA, H. NAGAE, and S. ABE
Serum Levels of Surfactant Proteins A and D Are Useful Biomarkers for Interstitial Lung Disease in Patients with Progressive Systemic Sclerosis
Am. J. Respir. Crit. Care Med., July 1, 2000; 162(1): 258 - 263.
[Abstract] [Full Text]


Home page
Postgrad. Med. J.Home page
S P Matusiewicz, W A H Wallace, and G K Crompton
Hypersensitivity pneumonitis associated with co-proxamol (paracetamol + dextropropoxyphene) therapy
Postgrad. Med. J., August 1, 1999; 75(886): 475 - 477.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. W. ZIEGENHAGEN, P. ZABEL, G. ZISSEL, M. SCHLAAK, and J. MULLER-QUERNHEIM
Serum Level of Interleukin 8 Is Elevated in Idiopathic Pulmonary Fibrosis and Indicates Disease Activity
Am. J. Respir. Crit. Care Med., March 1, 1998; 157(3): 762 - 768.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the European Respiratory Society.